| NO. |
Chemical Name |
CAS NO. |
| Intermediates of Alectinib |
|
RC009
|
6-bromo-7-methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one |
1256578-99-0 |
|
RC010
|
3,4-Dihydro-7-methoxy-2(1H)-naphthalenone |
4133-34-0 |
|
RC011
|
9-Bromo-8-hydroxy-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile |
1256579-06-2 |
|
RC013
|
3-hydrazinylbenzonitrile |
17672-26-3 |
| Intermediates of Neratinib |
|
RC092
|
3-Chloro-4-[(pyridin-2-yl)methyloxy]aniline |
524955-09-7 |
|
RC093
|
trans-4-Dimethylaminocrotonic acid hydrochloride |
848133-35-7 |
|
RC094
|
n-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl) acetamide |
848133-76-6 |
| Intermediates of Dolastoxin |
|
RC089
|
(1S,2R)-(+)-2-amino-1-phenyl-1-propanol |
37577-28-9 |
|
RC090
|
2-Methyl-2-propanyl (3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino) heptanoate hydrochloride (1:1) |
120205-48-3 |
|
RC091
|
((2R,3R)-3-((S)-1-(tertbutoxycarbonyl)pyrrolidin-2-yl)-3-Methoxy-2-Methylpropanoic |
120205-50-7 |
| Intermediates of Lapatinib |
|
RC022
|
2-aminoethylmethylsulfone hydrochloride |
104458-24-4 |
|
RC029
|
N-[3-Chloro-4-(3-fluorobenzyloxy)-phenyl]-6-iodoquinazolin-4-amine |
231278-20-9 |
| Intermediates of Fulvestrant |
|
RC052
|
(7α,17β)-7-(9-bromononyl)estra-1,3,5(10)-triene-3,17-diol |
875573-67-4 |
|
RC054
|
(7α,17β)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
875573-66-3 |
|
RC053
|
(7α,17β)-7-[9-(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estra- 1,3,5(10)- triene-3-diol -17oxyethyl |
875573-69-6 |
|
RC055
|
(7α,17β)-7-{[9-(4,4,5,5,5-pentafluoropentyl)thio]nonyl}-eatra-1,3,5(10)-triene-3,17-diol |
153004-31-0 |
|
RC056
|
4,4,5,5,5-Pentafluoro-1-pentanethiol |
148757-88-4 |
|
RC057
|
4,4,5,5,5-Pentafluoro-1-pentanol |
148043-73-6 |
| Intermediates of Lenalidomide |
|
RC073
|
Methyl 2-bromomethyl-3-nitrobenzoate |
98475-07-1 |
|
RC074
|
3-aminopiperidine-2,6-dione |
2353-44-8 |
|
RC075
|
2,6-dioxopiperidine-3-ammonium chloride |
24666-56-6 |
| Intermediates of Eribulin |
|
RC083
|
Grubbs Catalyst II |
246047-72-3 |
|
RC084
|
3-Fluoro-4-bromonitrobenzene |
185331-69-5 |
|
RC085
|
5-Bromo-2-pyridinecarbonitrile |
97483-77-7 |
|
RC086
|
(R)-(-)-Epichlorohydrin |
51594-55-9 |
| Intermediates of Dasatinib |
|
RC076
|
4,6-dichloro-2-methylpyrimidine |
1780-26-3 |
|
RC077
|
N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolcarboxamide |
302964-08-5 |
|
RC078
|
N-(2-hydroxyethyl)piperazine |
103-76-4 |
|
RC079
|
2-amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide |
302964-24-5 |
| Intermediates of Nilotinib |
|
RC080
|
Nilotinib base |
641571-10-0 |
|
RC081
|
4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-yl)benzoic acid |
641569-94-0 |
|
RC082
|
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
641571-11-1 |
| Intermediates of Imatinib Mesylate |
|
RC049
|
Imatinib base |
152459-95-5 |
|
RC047
|
4-[(4-methyl-1-piperaziny)methyl]benzoic acid |
106261-48-7 |
|
RC048
|
4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride |
106261-49-8 |
|
RC050
|
4-methyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
152460-10-1 |
| Intermediates of Erlotinib |
|
RC061
|
2-amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester |
179688-27-8 |
|
RC062
|
2-amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride |
183322-17-0 |
|
RC063
|
3-aminophenylacetylene |
54060-30-9 |
|
RC064
|
2-amino-4,5-bis-(2-methoxyethoxy)-benzoic acid methyl ester |
476168-17-9 |
|
RC065
|
4-chloro-6,7-bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
183322-18-1 |
|
RC066
|
6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
179688-29-0 |
